Wistar Institute Develops Promising Immune Therapy for Glioblastoma
PHILADELPHIA, PA — The Wistar Institute, led by Dr. David B. Weiner, has announced successful preclinical tests of a groundbreaking immune therapy for glioblastoma, a highly aggressive brain cancer with …
Wistar Institute Develops Promising Immune Therapy for Glioblastoma Read More